MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 130 filers reported holding MACROGENICS INC in Q4 2016. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $269,511 | -21.9% | 57,835 | -10.4% | 0.00% | – |
Q2 2023 | $345,267 | +40.7% | 64,536 | +88.5% | 0.00% | – |
Q1 2023 | $245,479 | +7.1% | 34,237 | +0.3% | 0.00% | – |
Q4 2022 | $229,120 | +94.2% | 34,146 | +0.1% | 0.00% | – |
Q3 2022 | $118,000 | -98.6% | 34,110 | -92.6% | 0.00% | -100.0% |
Q1 2019 | $8,259,000 | +41.6% | 459,335 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $5,834,000 | -40.8% | 459,335 | 0.0% | 0.00% | -20.0% |
Q3 2018 | $9,848,000 | -0.6% | 459,335 | -4.2% | 0.01% | 0.0% |
Q2 2018 | $9,904,000 | -17.9% | 479,615 | +0.0% | 0.01% | -16.7% |
Q1 2018 | $12,064,000 | +32.4% | 479,500 | 0.0% | 0.01% | +50.0% |
Q4 2017 | $9,111,000 | -1.8% | 479,500 | -4.5% | 0.00% | -20.0% |
Q3 2017 | $9,275,000 | +5.5% | 501,900 | 0.0% | 0.01% | +25.0% |
Q2 2017 | $8,788,000 | -19.5% | 501,900 | -14.5% | 0.00% | -33.3% |
Q1 2017 | $10,920,000 | -9.0% | 587,100 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $12,000,000 | -33.0% | 587,100 | -2.0% | 0.01% | -33.3% |
Q3 2016 | $17,910,000 | +10.8% | 598,800 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $16,162,000 | +44.9% | 598,800 | +0.6% | 0.01% | +50.0% |
Q1 2016 | $11,156,000 | -39.5% | 595,000 | 0.0% | 0.01% | -33.3% |
Q4 2015 | $18,427,000 | +39.2% | 595,000 | -3.7% | 0.01% | +28.6% |
Q3 2015 | $13,238,000 | -52.0% | 618,000 | -14.9% | 0.01% | -46.2% |
Q2 2015 | $27,570,000 | +21.0% | 726,100 | 0.0% | 0.01% | +30.0% |
Q1 2015 | $22,778,000 | -4.1% | 726,100 | +7.2% | 0.01% | -9.1% |
Q4 2014 | $23,753,000 | +124.0% | 677,300 | +33.5% | 0.01% | +120.0% |
Q3 2014 | $10,603,000 | -10.3% | 507,300 | -6.7% | 0.01% | 0.0% |
Q2 2014 | $11,819,000 | -8.9% | 543,900 | +16.6% | 0.01% | -16.7% |
Q1 2014 | $12,980,000 | +20.3% | 466,400 | +18.5% | 0.01% | +20.0% |
Q4 2013 | $10,794,000 | – | 393,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 2,115,000 | $37,034,000 | 8.81% |
INTERWEST VENTURE MANAGEMENT CO | 1,074,316 | $18,811,000 | 4.45% |
DAFNA Capital Management LLC | 119,200 | $2,087,000 | 1.49% |
BB BIOTECH AG | 2,350,112 | $41,150,000 | 1.26% |
TIGER MANAGEMENT L.L.C. | 239,667 | $4,197,000 | 0.82% |
Hood River Capital Management LLC | 576,193 | $10,089,000 | 0.70% |
Bellevue Group AG | 316,418 | $5,540,000 | 0.66% |
Rhenman & Partners Asset Management AB | 175,000 | $3,064,000 | 0.44% |
First Light Asset Management, LLC | 61,538 | $1,078,000 | 0.36% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 54,000 | $945,000 | 0.36% |